SCHEMBL28453033

SCHEMBL28453033

CC1(OC(N)=O)CCC(N(Cc2ccccc2)Cc2ccccc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 1/20 0.46
KDM4E B2RXH2 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
YTHDC1 Q96MU7 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
GRIN2B Q13224 1/20 0.36
RAB9A P51151 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
DPP8 Q6V1X1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20697131 0.80 KDM4E (0.45) CCR5KDM4ENPSR1ATMTDP1
SCHEMBL31266701 0.80 KDM4E (0.45) CCR5KDM4ENPSR1ATMTDP1
SCHEMBL28449490 0.79 OPRM1 (0.51) MEN1KMT2AGRIN2BRAB9A
SCHEMBL31630145 0.78 CCR5 (0.45) CCR5KDM4ENPSR1ATMTDP1
SCHEMBL24678312 0.77 KDM4E (0.47) CCR5KDM4ENPSR1ATMTDP1
SCHEMBL383265 0.77 CCR5 (0.47) CCR5KDM4ENPSR1ATMTDP1
SCHEMBL383264 0.77 CCR5 (0.47) CCR5KDM4ENPSR1ATMTDP1
SCHEMBL2144199 0.77 CCR5 (0.47) CCR5KDM4ENPSR1ATMTDP1
SCHEMBL9235731 0.76 CCR5 (0.48) CCR5KDM4ENPSR1ATMTDP1
SCHEMBL20575829 0.76 CCR5 (0.50) CCR5KDM4ENPSR1ATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111566089-B IRE1 small molecule inhibitors 康奈尔大学 2023-11-17 CN disclosed
CN-114423753-A Heterobicyclic amides as CD38 inhibitors 里邦医疗公司 2022-04-29 CN disclosed
CN-111566089-A IRE1 small molecule inhibitor 康奈尔大学 2020-08-21 CN disclosed